OpenURL Connection Search

Select item for more details and to access through your institution.

PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 203, doi. 10.1007/s00280-023-04506-x
By:
- Li, Chenxi;
- Hao, Meiqi;
- Fang, Zige;
- Ding, Jiatong;
- Duan, Sijia;
- Yi, Fengming;
- Wei, Yiping;
- Zhang, Wenxiong
Publication type:
Article
Determination of 5-azacitidine in human plasma by LC–MS/MS: application to pharmacokinetics pilot study in MDS/AML patients.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 231, doi. 10.1007/s00280-023-04505-y
By:
- Donnette, Melanie;
- Osanno, Loic;
- Giocanti, Madeleine;
- Venton, Geoffroy;
- Farnault, Laure;
- Berda-Haddad, Yael;
- Costello, Régis;
- Caroline, Solas;
- Ouafik, L.'Houcine;
- Ciccolini, Joseph;
- Fanciullino, Raphaëlle
Publication type:
Article
Assay performance and stability of uracil and dihydrouracil in clinical practice.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 257, doi. 10.1007/s00280-023-04518-7
By:
- Knikman, Jonathan E.;
- Rosing, Hilde;
- Guchelaar, Henk-Jan;
- Cats, Annemieke;
- Beijnen, Jos H.
Publication type:
Article
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 267, doi. 10.1007/s00280-023-04513-y
By:
- Aslanis, Vassilios;
- Slack, Robert J.;
- MacKinnon, Alison C.;
- McClinton, Catherine;
- Tantawi, Susan;
- Gravelle, Lise;
- Nilsson, Ulf J.;
- Leffler, Hakon;
- Brooks, Ashley;
- Khindri, Sanjeev K.;
- Marshall, Richard P.;
- Pedersen, Anders;
- Schambye, Hans;
- Zetterberg, Fredrik
Publication type:
Article
Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 247, doi. 10.1007/s00280-023-04512-z
By:
- de Jong, Loek A. W.;
- Lambert, Marie;
- van Erp, Nielka P.;
- de Vries, Lukas;
- Chatelut, Etienne;
- Ottevanger, Petronella B.
Publication type:
Article
Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 281, doi. 10.1007/s00280-023-04511-0
By:
- Shafer, Danielle;
- Kagan, Amanda B.;
- Rudek, Michelle A.;
- Kmieciak, Maciej;
- Tombes, Mary Beth;
- Shrader, Ellen;
- Bandyopadhyay, Dipankar;
- Hudson, Daniel;
- Sankala, Heidi;
- Weir, Caryn;
- Lancet, Jeffrey E.;
- Grant, Steven
Publication type:
Article
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 239, doi. 10.1007/s00280-023-04510-1
By:
- Meneses-Lorente, Georgina;
- Guerini, Elena;
- Mercier, Francois;
- Parrott, Neil;
- Kowalski, Karey;
- Chow-Maneval, Edna;
- Buchheit, Vincent;
- Bergthold, Guillaume;
- Fox, Elizabeth;
- Phipps, Alex;
- Djebli, Nassim
Publication type:
Article
Evaluating the indotecan–neutropenia relationship in patients with solid tumors by population pharmacokinetic modeling and sigmoidal E<sub>max</sub> regressions.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 219, doi. 10.1007/s00280-023-04509-8
By:
- Beumer, Jan H.;
- Kennard, Benjamin C.;
- Holleran, Julianne L.;
- Moore, Nancy;
- Zlott, Jennifer;
- Miller, Brian M.;
- Kummar, Shivaani;
- Chen, Alice;
- Doroshow, James;
- Park, Wansu;
- Gobburu, Jogarao;
- Dunn, Allison
Publication type:
Article

Found: 8